Sugarloaf Wealth Management LLC Purchases 90 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Sugarloaf Wealth Management LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,764 shares of the healthcare conglomerate’s stock after purchasing an additional 90 shares during the quarter. UnitedHealth Group comprises about 0.7% of Sugarloaf Wealth Management LLC’s holdings, making the stock its 23rd largest position. Sugarloaf Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,955,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. XML Financial LLC boosted its holdings in shares of UnitedHealth Group by 6.7% in the 4th quarter. XML Financial LLC now owns 3,518 shares of the healthcare conglomerate’s stock worth $1,852,000 after purchasing an additional 221 shares in the last quarter. Regal Investment Advisors LLC raised its position in shares of UnitedHealth Group by 5.1% in the 4th quarter. Regal Investment Advisors LLC now owns 3,379 shares of the healthcare conglomerate’s stock worth $1,779,000 after acquiring an additional 164 shares in the last quarter. Keyes Stange & Wooten Wealth Management LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $244,000. Whitford Management LLC grew its stake in shares of UnitedHealth Group by 3,609.6% in the 4th quarter. Whitford Management LLC now owns 34,425 shares of the healthcare conglomerate’s stock worth $18,124,000 after buying an additional 33,497 shares during the last quarter. Finally, Visionary Wealth Advisors boosted its stake in UnitedHealth Group by 3.2% during the 4th quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock valued at $649,000 after purchasing an additional 38 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.2 %

UnitedHealth Group stock traded up $1.04 during mid-day trading on Tuesday, reaching $584.60. 644,647 shares of the company were exchanged, compared to its average volume of 3,941,328. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The business has a fifty day moving average of $582.58 and a 200 day moving average of $528.49. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The firm has a market cap of $538.06 billion, a P/E ratio of 35.55, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the firm earned $6.14 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. Robert W. Baird increased their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. UBS Group boosted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 1st. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.